Tirzepatide 10

Tirzepatide 10 mg from Medipharma is the innovative solution for effective blood glucose control in type 2 diabetes and sustainable weight loss, administered as a weekly injection and activating GLP-1 and GIP receptors as a dual agonist to promote insulin release, inhibit glucagon and reduce appetite while slowing gastric emptying. In clinical trials, patients with this dose achieved an average of 22 kg of weight reduction in 72 weeks, combined with diet and exercise for optimal results of up to 20 percent body fat reduction. The application is safe and easy, with usually mild side effects such as temporary nausea that subsides quickly, and Medipharma guarantees the highest quality